GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Superinvestors holding GNLX, Q2 2026
No superinvestor reported holding GNLX in Q2 2026.